New Agents Changing Management of Advanced Prostate Cancer


New therapeutic agents are changing how patients with advanced prostate cancer are managed. John Schieszer reports in today's Medical Minute that denosumab along with immunotherapy may help make advanced prostate cancer become more of a chronic illness than a terminal disease.
Loading links....
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters